K Health Review
Best for: users who want general primary care with GLP-1 prescribing as one available option, not a single-condition weight-loss funnel
K Health is a large enterprise telehealth platform built around an AI intake layer plus board-certified physician review. It is a primary-care-first product with health-system integrations (Cedars-Sinai, Hartford HealthCare, Hackensack Meridian) — GLP-1 prescribing is one clinical option within general primary care, not a dedicated weight-loss funnel.
Low confidence · Last verified 2026-04-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
K Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Preliminary | brand | $300 |
✓ Pros
- •Established US telehealth with health-system integrations (Cedars-Sinai, Hartford HealthCare, Hackensack Meridian)
- •AI intake reduces upfront friction for users who don't want to sit through a long questionnaire before seeing a clinician
- •Primary-care relationship rather than a single-condition funnel — useful for users who want one provider managing multiple conditions
✗ Cons
- •Not a GLP-1 specialty platform — weight management is ancillary to primary care, and GLP-1 prescribing is clinician-discretionary at the visit level
- •Pricing for GLP-1 specifically is not displayed publicly — needs direct confirmation from K Health support before placing readers
- •States served list and pharmacy partners are not publicly enumerated
Ready to start with K Health?
Starting at $300/month. See current pricing and start your free consultation.
Sources & methodology
Our K Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to K Health
Editorial score · methodology
Editorial score · methodology
Alloy
Best for: women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory
Editorial score · methodology
Frequently Asked Questions
Ready to start with K Health?
Starting at $300/month. See current pricing and start your free consultation.